Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Meds Catalog

Levetiracetam

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Catalog partial Not FDA-approved for animals AX Pharmaceutical Corp Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Storefront facts
Catalog refreshed
May 5, 2026, 10:05 a.m.

Roxee has a partial storefront projection for this medication. Some primary facts still need verification.

FDA applications
FDA application data refreshed
May 5, 2026, 10:00 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
May 5, 2026, 10:01 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: April 15, 2026

Updated: April 15, 2026, 10:04 AM UTC

Sources:
Image coming soon
Levetiracetam

Levetiracetam

Drug type: Generic ingredient • Branded profile • Not FDA-approved for animals

Both 85% storefront ready

Species: Both

Approval status: Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Levetiracetam

Anti-seizure medication used as monotherapy or adjunct therapy. Species commonly shown: Both.

Generic name
Levetiracetam
Brand names
AX Pharmaceutical Corp, Levetiracetam, X
Manufacturer
AX Pharmaceutical Corp
Species
Both
Completeness
85%
Validation
Incomplete
Brand names
AX Pharmaceutical Corp Levetiracetam X

Indications / Uses

Anti-seizure medication used as monotherapy or adjunct therapy.

Administration / How To Give

Oral

Storage

Store at room temperature.

Warnings / Contraindications

Dose adjustments may be needed in kidney disease.

  • Dose adjustments may be needed in kidney disease.

Side Effects

Sedation, ataxia; generally well tolerated.

FAQ

Both

Store at room temperature.

Related Medications

Afoxolaner Same category: Flea & Tick Doxycycline Same category: Flea & Tick Fluralaner 13.64% 12-Week Chew Same category: Flea & Tick Fluralaner Chew Tablets Same category: Flea & Tick Fluralaner Spot-On Solution Same category: Flea & Tick Imidacloprid Same category: Flea & Tick

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

Anti-seizure medication used as monotherapy or adjunct therapy.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Dose adjustments may be needed in kidney disease
  • wobbly/unsteady walking (1 reports)
  • trouble breathing (1 reports)
  • Loss of appetite (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Major cautions & emergency warning signs

Side effects to monitor:

  • Dose adjustments may be needed in kidney disease
  • wobbly/unsteady walking
  • trouble breathing
  • Loss of appetite

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Trouble breathing (dyspnea) (1 reports)
  • Loss of appetite (1 reports)

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Facial swelling or hives.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: AX Pharmaceutical Corp
Identifiers:
NDC Package: 62157-130-01 NDC Package: 62157-400-01 NDC Package: 62157-697-01 NDC Package: 73377-029-01 NDC Package: 73377-029-02 NDC Package: 73377-029-03 NDC Package: 73377-029-04 NDC Product: 62157 NDC Product: 73377

Warnings / Contraindications

Dose adjustments may be needed in kidney disease.

  • High: Dose adjustments may be needed in kidney disease.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
31
Species represented
2
Grouped by Body System
Digestive (2) · Loss of appetite, Bloody diarrhoea Neurologic (3) · Unsteady walking (ataxia), Circling - neurological disorder, Cerebellar ataxia Behavior (2) · Biting -aggression, Behavioral disorder (unspecified) Other (25) · Trouble breathing (dyspnea), Electrolyte disorder, Easily startled
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Cat 1
Other 1 Dog 1
Digestive 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Cat 1
Other 1 Cat 1

Species coverage: Dog (17) Cat (15)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Cat Serious - 1
Other Dog Serious - 1
Digestive Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Neurologic Cat Serious - 1
Neurologic Cat Serious - 1
Other Dog Serious - 1
Digestive Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Behavior Cat Serious - 1
Behavior Dog Serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Source metadata:

Storage & Handling

Store at room temperature.

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

4

FOI

0
No FOI links yet.

Levetiracetam SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Levetiracetam. Use the source link for the full official labeling record.

X SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for X. Use the source link for the full official labeling record.

X SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for X. Use the source link for the full official labeling record.

AX Pharmaceutical Corp SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for AX Pharmaceutical Corp. Use the source link for the full official labeling record.
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: AX Pharmaceutical Corp Levetiracetam X
Manufacturer mapping: AX Pharmaceutical Corp
Case-reported brands (openFDA): MSK
Catalog species: Both
NDC: Packages 62157-130-01 62157-400-01 62157-697-01 73377-029-01 73377-029-02 73377-029-03 • Products 62157 73377
Safety (openFDA)
Top reactions: Dog 29 • Cat 13 • View
Case summaries: 8 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Dose adjustments may be needed in kidney disease. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Trouble breathing (dyspnea) (1) Loss of appetite (1) Electrolyte disorder (1) Easily startled (1) Dysphoria (1) Dysphagia (1) Dull (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NDC Package: 62157-130-01 NDC Package: 62157-400-01 NDC Package: 62157-697-01 NDC Package: 73377-029-01 NDC Package: 73377-029-02 NDC Package: 73377-029-03 NDC Package: 73377-029-04 NDC Product: 62157 NDC Product: 73377
Package NDC Product NDC Form / Route Status
62157-130-01 62157 -
62157-400-01 62157 -
62157-697-01 62157 -
73377-029-01 73377 -
73377-029-02 73377 -
73377-029-03 73377 -
73377-029-04 73377 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • Levetiracetam SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • X SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • X SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • AX Pharmaceutical Corp SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 32 Clinical 47 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-05-05)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-05-03)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-30)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-29)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-28)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-27)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-26)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-25)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-17)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-15)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-15)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-04-11)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-02-12)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-21)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-20)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-19)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-17)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-15)
Recent Revisions
  • side_effects updated 2026-05-05 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-05-05 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-05-05 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-05-03 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-05-03 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-05-03 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-29 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-29 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-29 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-28 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-28 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-28 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-27 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-27 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-27 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-26 10:06 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-26 10:06 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published

Data source: FDA Animal Drugs @ FDA (public search export).

Usage

Anti-seizure medication used as monotherapy or adjunct therapy.

Contraindications

Dose adjustments may be needed in kidney disease.

Side Effects

Sedation, ataxia; generally well tolerated.

Source: FDA openFDA • Reference

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Dog Bloody diarrhoea (1) • Dog

Showing top 5 for Digestive.

Neurologic
Unsteady walking (1) • Cat Circling - neurological disorder (1) • Cat Cerebellar ataxia (1) • Cat

Showing top 5 for Neurologic.

Behavior
Biting -aggression (1) • Cat Behavioral disorder (1) • Dog

Showing top 5 for Behavior.

Other
Trouble breathing (1) • Dog Electrolyte disorder (1) • Cat Easily startled (1) • Dog Dysphoria (1) • Cat Dysphagia (1) • Cat
Show more (20)
Dull (1) • Cat Dilated pupils (1) • Cat Dermatitis (1) • Cat Decreased activity (1) • Dog Death by euthanasia (1) • Cat Death (1) • Dog Corneal ulcer (1) • Dog Confusion (1) • Dog Bumping into walls (1) • Dog Blinking (1) • Dog Blindness (1) • Dog Asphyxia (1) • Dog Arthritis (1) • Cat Apathy (1) • Dog Anaemia NOS (1) • Dog Allergy NOS (1) • Dog Abnormal serum protein NOS (1) • Cat Abnormal movement NOS (1) • Cat Abnormal menace reflex test (1) • Cat Abdominal pain (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Dog (other), Female, 1.5 year, 21.32 kilogram • Drug: MSK, Unknown, Dose: 500 Milligram per animal • Reactions: Seizure NOS, Blindness, Asphyxia, Death • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-075227
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Female
  • Age: 1.50 Year
  • Weight: 21.320 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Dose: 500 Milligram per animal
Reactions Reported:
Seizure NOS Blindness Asphyxia Death
Outcomes: Died

Dog, ['Terrier (unspecified)', 'Dog (unknown)'], Male, 14 year, 9.072 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Death, Seizure NOS, Renal failure, Anaemia NOS, Loss of appetite… • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-074272
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 14.00 Year
  • Weight: 9.072 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Death Seizure NOS Renal failure Anaemia NOS Loss of appetite Sleepiness - systemic disorder Confusion Shaking Unable to rise Bumping into walls Corneal ulcer Increased drinking Squinting Ocular discharge Biting -aggression Elevated alanine aminotransferase Medication error NOS General illness
Outcomes: Died

Dog, Terrier - Boston, Male, 3 year, 10.886 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Seizure NOS • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074340
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 3.00 Year
  • Weight: 10.886 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Seizure NOS
Outcomes: Ongoing

Dog, ['Shepherd (unspecified)', 'Dog (unknown)'], Female, 11 year, 22.498 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vestibular disorder NOS, Wobbliness, Horizontal nystagmus, Head tilt - neurological disorder, Nausea… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-072782
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 11.00 Year
  • Weight: 22.498 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Vestibular disorder NOS Wobbliness Horizontal nystagmus Head tilt - neurological disorder Nausea Vomiting Lack of efficacy - NOS Overdose
Outcomes: Ongoing

Dog, Shiba Inu, Male, 6 year, 14.4 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Increased seizure frequency • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-071447
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 6.00 Year
  • Weight: 14.400 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Increased seizure frequency
Outcomes: Ongoing

Cat, Domestic Mediumhair, Male, 17 year, 4.536 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Medication error NOS, Skin lesion NOS, Dermatitis, Vomiting • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-073128
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 17.00 Year
  • Weight: 4.536 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Medication error NOS Skin lesion NOS Dermatitis Vomiting
Outcomes: Ongoing

Dog, ['Hound - Basset', 'Collie (unspecified)'], Male, 11 year, 27.488 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Seizure NOS • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-071469
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 11.00 Year
  • Weight: 27.488 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Seizure NOS
Outcomes: Recovered/Normal

Cat, Domestic Mediumhair, Male, 14.6 year, 5 kilogram • Drug: MSK, Unknown • Reactions: Not eating, Limping, Low sodium-potassium ratio, Elevated alanine aminotransferase, Gait abnormality… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-066416
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 14.60 Year
  • Weight: 5.000 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Not eating Limping Low sodium-potassium ratio Elevated alanine aminotransferase Gait abnormality Hard stool Skin inflammation NOS Arthritis Swelling NOS
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

Store at room temperature.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.